Adiponectin receptor expression in human malignant tissues

Hormones and Cancer

Volumn 1, Issue 3, 2010, Pages 136-145

  Chou, Sharon H ^a   Tseleni Balafouta, Sofia ^b   Moon, Hyun Seuk ^a   Chamberland, John P ^a   Liu, Xiaowen ^a   Kavantzas, Nikolaos ^b   Mantzoros, Christos S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adiponectin; Adiponectin receptor; Malignancy; Obesity

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; MESSENGER RNA;

ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; MALE; MELANOMA; OBESITY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; OBESITY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADIPONECTIN; RNA, MESSENGER;

EID: 77955553051     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-010-0017-7     Document Type: Article

References (50)

1. Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371: 569-578.
2. Calle EE, Thun MJ (2004) Obesity and cancer. Oncogene 23: 6365-6378.
3. Barb D, Williams CJ, Neuwirth AK et al (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 86: s858-s866.
4. Guadagni F, Roselli M, Martini F et al (2009) Prognostic significance of serum adipokine levels in colorectal cancer patients. Anticancer Res 29: 3321-3327.
5. Kumor A, Daniel P, Pietruczuk M et al (2009) Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 24: 275-281.
6. Wei EK, Giovannucci E, Fuchs CS et al (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97: 1688-1694.
7. Korner A, Pazaitou-Panayiotou K, Kelesidis T et al (2007) Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92: 1041-1048.
8. Dal Maso L, Augustin LS, Karalis A et al (2004) Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 89: 1160-1163.
9. Horiguchi A, Ito K, Sumitomo M et al (2008) Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma. Jpn J Clin Oncol 38: 106-111.
10. Spyridopoulos TN, Petridou ET, Skalkidou A et al (2007) Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer 120: 1573-1578.
11. Williams CJ, Mitsiades N, Sozopoulos E et al (2008) Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer 15: 289-299.
12. Michalakis K, Williams CJ, Mitsiades N et al (2007) Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomark Prev 16: 308-313.
13. Petridou ET, Mitsiades N, Gialamas S et al (2007) Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies. Oncology 73: 261-269.
14. Dalamaga M, Migdalis I, Fargnoli JL et al (2009) Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control 20: 625-633.
15. Pinthus JH, Kleinmann N, Tisdale B et al (2008) Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur Urol 54: 866-873.
16. Barresi V, Grosso M, Giuffre G et al (2009) The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. J Clin Pathol 62: 705-709.
17. Molica S, Vitelli G, Cutrona G et al (2008) Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia. Int J Hematol 88: 374-380.
18. Samanic C, Chow WH, Gridley G et al (2006) Relation of body mass index to cancer risk in 362, 552 Swedish men. Cancer Causes Control 17: 901-909.
19. Modesitt SC, van Nagell JR Jr (2005) The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv 60: 683-692.
20. Hsing AW, Nam JM, Co Chien HT et al (1996) Risk factors for adrenal cancer: an exploratory study. Int J Cancer 65: 432-436.
21. Lacey JV Jr, Swanson CA, Brinton LA et al (2003) Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 98: 814-821.
22. Reeves GK, Pirie K, Beral V et al (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335: 1134.
23. Gomez-Abellan P, Gomez-Santos C, Madrid JA et al (2010) Circadian expression of adiponectin and its receptors in human adipose tissue. Endocrinology 151: 115-122.
24. Nannipieri M, Bonotti A, Anselmino M et al (2007) Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state. Int J Obes (Lond) 31: 1843-1848.
25. Rasmussen MS, Lihn AS, Pedersen SB et al (2006) Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity (Silver Spring) 14: 28-35.
26. Holick CN, Giovannucci EL, Stampfer MJ et al (2007) Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer 120: 140-146.
27. Koebnick C, Michaud D, Moore SC et al (2008) Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomark Prev 17: 1214-1221.
28. Thune I, Olsen A, Albrektsen G et al (1993) Cutaneous malignant melanoma: association with height, weight and body-surface area. A prospective study in Norway. Int J Cancer 55: 555-561.
29. Mantzoros CS, Trakatelli M, Gogas H et al (2007) Circulating adiponectin levels in relation to melanoma: a case-control study. Eur J Cancer 43: 1430-1436.
30. Karapanagiotou EM, Tsochatzis EA, Dilana KD et al (2008) The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). Lung Cancer 61: 391-397.
31. Dos Santos E, Benaitreau D, Dieudonne MN et al (2008) Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol Rep 20: 971-977.
32. Konturek PC, Burnat G, Rau T et al (2008) Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci 53: 597-605.
33. Pfeiler G, Treeck O, Wenzel G et al (2009) Influence of insulin resistance on adiponectin receptor expression in breast cancer. Maturitas 63: 253-256.
34. Yamamoto Y, Hirose H, Saito I et al (2002) Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 103: 137-142.
35. Brakenhielm E, Veitonmaki N, Cao R et al (2004) Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A 101: 2476-2481.
36. Wang Y, Lam KS, Xu JY et al (2005) Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280: 18341-18347.
37. Luo Z, Saha AK, Xiang X et al (2005) AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26: 69-76.
38. Sugiyama M, Takahashi H, Hosono K et al (2009) Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol 34: 339-344.
39. Miyazaki T, Bub JD, Uzuki M et al (2005) Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem Biophys Res Commun 333: 79-87.
40. Bowman T, Garcia R, Turkson J et al (2000) STATs in oncogenesis. Oncogene 19: 2474-2488.
41. Testa JR, Bellacosa A (2001) AKT plays a central role in tumorigenesis. Proc Natl Acad Sci U S A 98: 10983-10985.
42. Reddy KB, Nabha SM, Atanaskova N (2003) Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 22: 395-403.
43. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945.
44. Arita Y, Kihara S, Ouchi N et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83.
45. Petridou E, Mantzoros C, Dessypris N et al (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 88: 993-997.
46. Otani K, Kitayama J, Yasuda K et al (2009) Adiponectin suppresses tumorigenesis in Apc(Min)(/+) mice. Cancer Lett 288: 177-182.
47. Ishikawa M, Kitayama J, Yamauchi T et al (2007) Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci 98: 1120-1127.
48. Ogunwobi OO, Beales IL (2008) Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol 285: 43-50.
49. Nakayama S, Miyoshi Y, Ishihara H et al (2008) Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis. Breast Cancer Res Treat 112: 405-410.
50. Fujisawa T, Endo H, Tomimoto A et al (2008) Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 57: 1531-1538.